Search
for
Sort by
Research 541–570 of 1000+
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- Dysregulated behaviour of hair follicle stem cells triggers alopecia and provides potential therapeutic targets
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Modulating Aging and Aging-related Symptoms Using Endogenous Small Molecules
- Immune deficiency–related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Human long-term deregulated circadian rhythm alters regenerative properties of skin and hair precursor cells
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Hair graying and loss induced by imatinib mesylate
- Periocular Manifestations of Afatinib Therapy
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- SDRIFE Induced by Tofacitinib
- Autoimmune Hair Loss Induced by Alloantigen in C57BL/6 Mice.
- Hair Growth After Gefitinib Treatment
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Alopecia areata-like hair loss after a tick bite
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- A Successful Treatment of Alopecia Universalis with Ruxolitinib